In addition to better blood sugar management, GLP-1 medications often facilitate weight loss and can provide cardiovascular protective benefits for patients with a history of heart disease
Conditions containing heart, coronoary, cadrio*, myo* that did not mention diabetes were considered for this analysis
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): a randomized, double-blind, placebo-controlled trial
5.2 Oxyntomodulin as an endogenous polypharmacologic signal As discussed in Section 4.4, it also plays a central role in appetite regulation in the context of metabolic peptides
More research is needed into the effects of individual nutrients, specific foods, and dietary patterns in humans